Devices & Diagnostics Letter
Oct. 1, 2012
| Vol.
39 No.
39
FDA Plans Guidance on Device Enhancement versus Recall
The FDA plans to issue clarifying guidance to address confusion among devicemakers about what exactly constitutes an enhancement and what qualifies as a recall, a CDRH official says.
This article is viewable by subscribers only. To view this article, please select an option below.
|